ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,0874
-0,19%
Bitcoin
66.774,41
-0,24%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Aoxing Pharmaceutical Company New (delisted) (AXN)

  7. Aoxing Pharmaceutical Company New (delisted) (AXN) News

AXN

Aoxing Pharmaceutical Company New (delisted) (AXN)

Aoxing Pharmaceutical Company New (delisted)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:AXN
DatumZeitQuelleÜberschriftSymbolFirma
17/10/201719h28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
06/10/201722h17Edgar (US Regulatory)(25)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
06/10/201712h03Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
29/09/201712h04Edgar (US Regulatory)Withdrawal of Registration Statement (ammendment) (aw)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/09/201712h04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
27/09/201721h10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
26/09/201717h03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
25/09/201712h02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/08/201722h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
22/06/201722h37Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
15/05/201714h39Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/05/201716h21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/05/201716h20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
17/02/201718h34Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
14/02/201723h41Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
14/11/201623h07Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
05/10/201622h33Edgar (US Regulatory)Annual Report (10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/09/201622h17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
23/06/201613h56Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
16/05/201613h06Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
03/05/201612h04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
03/05/201612h03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
08/02/201614h30PR Newswire (US)Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%AMEX:AXNAoxing Pharmaceutical Company New (delisted)
08/02/201614h18Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
01/02/201614h30PR Newswire (US)Aoxing Pharma Appoints Dr. James Chen as Chief Financial OfficerAMEX:AXNAoxing Pharmaceutical Company New (delisted)
01/02/201612h05Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/01/201622h35Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
10/12/201514h30PR Newswire (US)Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of ShanghaiAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/12/201514h30PR Newswire (US)Aoxing Pharma Announces Opening Of Government Funded Drug Research CenterAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/12/201514h00PR Newswire (US)Aoxing Pharma Announces Resignation of CFOAMEX:AXNAoxing Pharmaceutical Company New (delisted)
 Showing the most relevant articles for your search:AMEX:AXN

Kürzlich von Ihnen besucht

ASX
MEHN
BOV
BBASH395
BBASH395 Ex:19,75
USOTC
BADGA
Badger St Ethanol (GM)
BTRX
MLNBTC
COIN
CORALUST
Coral Swap
HUOB
POLYXETH
Polymesh
NASDAQ
LYRA
Lyra Therapeutics
BIT
UB48JK
Unicredit Bank
USOTC
UBIHF
Ubicom (GM)
TG
540H
Amundi Etf Msci Europe E...
USOTC
BTTX
Better Therapeutics (PK)
LSE
0JVV
Lumentum
HITB
CITYUSDT
Manchester City Fan Token
USOTC
TDCB
Third Century Bancorp (PK)
NASDAQ
COIDX
IDX Commodity Opportunit...
BIT
UB1X6N
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten